Revive

product on market Capsule FNX 🟢 Safety: 100/100
Brand: FNX
🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 70% of ingredients have research evidence
A Label Compliance Grade

Product Label

Label for Revive
📄 Open Full PDF View on NIH DSLD →
📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

3 Capsule(s) Serving Size
30 Servings
Other Combinations Product Type
70% Evidence Coverage

Supplement Facts — Evidence Check

30 IU (100% DV)
✅ 1.3× RDA — within safe limits 📚 177 studies (Tier A: 3, B: 90)
RDA 15mg This product: 20.1mg UL 1000mg
20 mg (100% DV)
✅ 1.4× RDA — within safe limits 📚 193 studies (Tier A: 5, B: 63)
RDA 14mg This product: 20mg UL 35mg
2 mg (100% DV)
✅ 1.5× RDA — within safe limits 📚 113 studies (Tier A: 3, B: 35)
RDA 1.3mg This product: 2mg UL 100mg
2 mg (100% DV)
✅ 1.5× RDA — within safe limits 📚 113 studies (Tier A: 3, B: 35)
RDA 1.3mg This product: 2mg UL 100mg
15 mg (100% DV)
✅ 1.4× RDA — within safe limits 📚 258 studies (Tier A: 6, B: 134)
RDA 11mg This product: 15mg UL 40mg
70 mcg (100% DV)
✅ 1.3× RDA — within safe limits 📚 172 studies (Tier A: 0, B: 67)
RDA 0.055mg This product: 0.07mg UL 0.4mg
120 mcg (100% DV)
📊 3.4× RDA — above typical dose 📚 197 studies (Tier A: 1, B: 55)
RDA 0.035mg This product: 0.12mg
FNx Max T Complex
1300 mg
FNx Adrenal Complex
250 mg
Bioavailability Booster Complex
50 mg

Other Ingredients

Gelatin

Label Claims — Verification

❓ Nutrient
❓ All Other
❓ Structure/Function
All Other (98% of products) Structure/Function (81% of products) Nutrient (56% of products) Qualified Health (2% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

🧪 Formulation Notes

Natural Testosterone

Product Details

DSLD Entry Date 2022-01-22
Product Type Other Combinations
Form Capsule
Brand FNX
DSLD ID 264145
Data Updated 2026-04-11

Research Evidence

253 Research Sources
55 Avg Quality Score
128 Meta Analysis
52 Systematic Review
41 Rct
24 Clinical Trial
3 Regulatory Source
1 Narrative Review
1 Other
1 Guideline
1 Openfda Safety
A Vitamin E supplementation in pregnancy
Meta Analysis The Cochrane database of systematic reviews 2015
PubMed DOI
A Vitamin E for Alzheimer's dementia and mild cognitive impairment
Systematic Review The Cochrane database of systematic reviews 2017
PubMed DOI Cochrane
A Vitamin E for Alzheimer's disease and mild cognitive impairment
Meta Analysis The Cochrane database of systematic reviews 2008
PubMed DOI Cochrane
A Vitamin E for Alzheimer's dementia and mild cognitive impairment
Meta Analysis The Cochrane database of systematic reviews 2012
PubMed DOI Cochrane
A Exercise for intermittent claudication
Meta Analysis The Cochrane database of systematic reviews 2017
PubMed DOI
A Effects of vitamin E supplementation on the risk and progression of AD: a systematic review and meta-analysis
Meta Analysis Nutritional neuroscience 2021
PubMed DOI
A Effect of vitamin E supplementation in rheumatoid arthritis: a systematic review and meta-analysis
Meta Analysis European journal of clinical nutrition 2023
PubMed DOI
A Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)
Rct JAMA 2011
PubMed DOI
A Vitamin E for Alzheimer's dementia and mild cognitive impairment
Meta Analysis The Cochrane database of systematic reviews 2017
PubMed DOI Cochrane
B Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: US Preventive Services Task Force Recommendation Statement.
Guideline JAMA 2022
PubMed DOI
View all evidence for Vitamin E →

Compare Similar Products

Vegetarian Vitamin E 400 IU
Vegetarian Vitamin E 400 IU VitaCeutical Labs 100
E 400 IU Succinate
E 400 IU Succinate Natural Factors 100
Sel-E-Chrom
Sel-E-Chrom Douglas Laboratories 100
Sel-E-Chrom
Sel-E-Chrom Douglas Laboratories 100
Sel-E-Chrom
Sel-E-Chrom Douglas Laboratories 100
View all Vitamin E products →
Vitamin E research & evidence Best Vitamin E rankings All Vitamin E products More from FNX View on NIH DSLD →